NOVARTIS PHARMA AG
Lichtstrasse 35 – Basel – 4056
VAT: CHE116268023MWST
http://www.novartis.com
Complicit EU Projects
Within the Horizon 2020 (2014-2020) framework, NOVARTIS PHARMA AG has received € 0.0 for its participation in a total of 13 project(s) with a total cost of € 435,157,171.
| Start YYYYMMDD |
End YYYYMMDD |
Project ID | Project Name | Themes | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2019-09-01 | 2024-08-31 | 831458 | Trials@Home | participant | € 0.0 | € 39,148,297 | 1 | 33 | CORDIS ↪ | |
| 2019-04-01 | 2024-03-31 | 820820 | MOBILISE-D | drug discovery · multiple sclerosis · sensors · health care services · cardiology | participant | € 0.0 | € 49,911,564 | 2 | 38 | CORDIS ↪ |
| 2021-10-01 | 2026-09-30 | 101034427 | SCREEN4CARE | family planning · genomes | participant | € 0.0 | € 25,423,568 | 1 | 37 | CORDIS ↪ |
| 2020-01-01 | 2022-12-31 | 853992 | PharmaLedger | governance · big data · cryptography · business intelligence · health care services | participant | € 0.0 | € 22,118,324 | 2 | 30 | CORDIS ↪ |
| 2020-11-01 | 2025-10-31 | 945473 | ARDAT | drug safety · gene therapy · immunology · genomes · cells technologies | participant | € 0.0 | € 25,490,491 | 1 | 34 | CORDIS ↪ |
| 2019-04-01 | 2024-03-31 | 821520 | ConcePTION | governance · pharmaceutical drugs · obstetrics · ecosystems | participant | € 0.0 | € 28,657,491 | 3 | 65 | CORDIS ↪ |
| 2017-10-01 | 2021-09-30 | 777364 | EQIPD | neurobiology · data science · alzheimer · governance · machine learning | participant | € 0.0 | € 9,360,691 | 1 | 31 | CORDIS ↪ |
| 2019-11-01 | 2023-04-30 | 853966 | EU-PEARL | governance · tuberculosis | participant | € 0.0 | € 25,938,047 | 1 | 41 | CORDIS ↪ |
| 2021-11-01 | 2026-10-31 | 101034344 | EPND | neurobiology · data science · alzheimer · parkinson | participant | € 0.0 | € 19,005,502 | 1 | 29 | CORDIS ↪ |
| 2018-10-01 | 2023-03-31 | 812968 | PERICO | drug discovery · biochemistry · cell biology · genomes | partner | € nan | € 3,974,527 | 1 | 16 | CORDIS ↪ |
| 2017-11-01 | 2023-10-31 | 777377 | LITMUS | drug discovery · diabetes · hepatology · obesity | participant | € 0.0 | € 47,281,406 | 1 | 60 | CORDIS ↪ |
| 2018-04-01 | 2023-03-31 | 777500 | IMI-PainCare | drug discovery · surgery · pharmaceutical drugs · pathophysiology · pharmacokinetics | participant | € 0.0 | € 23,405,673 | 1 | 41 | CORDIS ↪ |
| 2018-06-01 | 2025-05-31 | 777394 | AIMS-2-TRIALS | epilepsy · personalized medicine | participant | € 0.0 | € 115,441,584 | 1 | 57 | CORDIS ↪ |
Within the Horizon Europe (2021-2027) framework, NOVARTIS PHARMA AG has received € 0.0 for its participation in a total of 1 project(s) with a total cost of € 7,665,520.
| Start YYYYMMDD |
End YYYYMMDD |
Project ID | Project Name | Themes | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2022-10-01 | 2026-09-30 | 101057286 | IMPACTIVE | pharmaceutical drugs · pollution · chemical process engineering · sustainable economy · chemical sciences | associatedPartner | € nan | € 7,665,520 | 1 | 20 | CORDIS ↪ |
Within the FP7 (2007-2013) framework, NOVARTIS PHARMA AG has received € 2,400.0 for its participation in a total of 5 project(s) with a total cost of € 123,959,027.
| Start YYYYMMDD |
End YYYYMMDD |
Project ID | Project Name | Themes | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2009-06-15 | 2015-06-14 | 115003 | SAFE-T | data science · databases · pathology · modeling of diseases spread | coordinator | € nan | € 36,427,294 | 1 | 26 | CORDIS ↪ |
| 2008-12-01 | 2012-11-30 | 223524 | PLASTICISE | neurobiology · alzheimer · pharmaceutical drugs · stroke | participant | € 2,400.0 | € 6,767,728 | 1 | 16 | CORDIS ↪ |
| 2011-03-01 | 2016-08-31 | 115156 | DDMORE | ontology · software · public health · ecosystems · mathematical model | participant | € nan | € 23,063,274 | 1 | 28 | CORDIS ↪ |
| 2012-03-01 | 2018-02-28 | 115303 | ABIRISK | rheumatology · databases · immunisation · multiple sclerosis · gastroenterology | coordinator | € nan | € 32,851,056 | 2 | 38 | CORDIS ↪ |
| 2009-09-01 | 2015-02-28 | 115008 | NEWMEDS | drug discovery · cognitive neuroscience · pharmaceutical drugs · schizophrenia · machine learning | participant | € nan | € 24,849,675 | 1 | 20 | CORDIS ↪ |